| |
| |
|
| Insider
Information: |
Walker Paul Edward |
| Relationship: |
|
| City: |
Timonium |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
15 |
|
| Direct
Shares |
11,541 |
|
|
Indirect Shares
|
81,301,488 |
|
|
| Direct
Value |
$1,915 |
|
|
|
Indirect Value
|
$325,943,714 |
|
|
| Total
Shares |
81,313,029 |
|
|
| Total
Value |
$325,945,629 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -13.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tesaro, Inc. |
TSRO |
Director |
2014-06-02 |
4,041 |
2012-10-15 |
0 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
Director |
2016-06-01 |
7,500 |
2016-06-01 |
0 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
2019-05-07 |
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2023-06-13 |
114 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2020-07-24 |
0 |
2022-05-25 |
0 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2023-07-17 |
24,471,264 |
Premium* |
|
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
|
Bright Health Group Inc. |
BHG |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
|
Trillium Therapeutics Inc |
TRIL |
Director |
2021-11-17 |
0 |
2021-11-17 |
0 |
Premium* |
|
|
Allakos Inc. |
ALLK |
Director |
2022-09-21 |
0 |
2022-09-21 |
3,386,400 |
Premium* |
|
|
Korro Bio |
KRRO |
|
|
0 |
2024-04-22 |
1,090,793 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRRO |
Korro Bio |
|
– – • |
2024-04-22 |
4 |
B |
$56.00 |
$999,992 |
I/I |
17,857 |
1,090,793 |
0.01 |
- |
|
| KRRO |
Korro Bio |
10% Owner |
– – • |
2023-11-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,072,936 |
|
- |
|
| SVRA |
Savara Inc |
10% Owner |
– – • |
2023-07-17 |
4 |
B |
$3.00 |
$999,999 |
I/I |
333,333 |
24,471,264 |
1.5 |
% |
|
| MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
– – • |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
I/I |
30,114 |
114 |
0 |
- |
|
| MIRM |
Mirum Pharmaceuticals, In... |
10% Owner |
– – • |
2023-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
0 |
- |
|
| AKUS |
Akouos, Inc. |
10% Owner |
– – • |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,294,207) |
0 |
0 |
- |
|
| ALLK |
Allakos Inc. |
Director |
– • – |
2022-09-21 |
4 |
B |
$5.02 |
$19,999,680 |
I/I |
3,984,000 |
3,386,400 |
2.1 |
% |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2022-05-25 |
4 |
S |
$0.08 |
$362,720 |
I/I |
(4,445,093) |
0 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2022-05-24 |
4 |
S |
$0.07 |
$387,943 |
I/I |
(5,931,843) |
4,445,093 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2022-04-11 |
4 |
B |
$1.90 |
$6,802,999 |
I/I |
3,580,526 |
948,948 |
1.5 |
- |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2021-12-22 |
4 |
S |
$0.91 |
$444,853 |
I/I |
(459,700) |
2,563,257 |
0 |
- |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.32 |
$49,630 |
I/I |
(37,570) |
3,022,957 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Director |
– • – |
2021-11-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(5,736,363) |
0 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-18 |
4 |
B |
$0.00 |
$0 |
I/I |
1,851,852 |
7,789,850 |
1.42 |
- |
|
| GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
– – • |
2021-06-28 |
4 |
B |
$19.00 |
$19,950,000 |
I/I |
1,050,000 |
7,692,298 |
1.5 |
- |
|
| GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
– – • |
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
6,642,298 |
6,642,298 |
0 |
- |
|
| BHG |
Bright Health Group Inc. |
10% Owner |
– – • |
2021-06-28 |
4 |
B |
$18.00 |
$34,999,992 |
I/I |
1,944,444 |
23,983,073 |
1.5 |
% |
|
| BHG |
Bright Health Group Inc. |
10% Owner |
– – • |
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
69,963,828 |
22,288,629 |
0 |
- |
|
| MRKR |
Marker Therapeutics Inc |
10% Owner |
– – • |
2021-03-16 |
4 |
B |
$1.75 |
$9,999,999 |
I/I |
5,714,285 |
10,714,285 |
1.5 |
- |
|
| SVRA |
Savara Inc |
10% Owner |
– – • |
2021-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
24,137,931 |
|
% |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2020-12-04 |
4 |
B |
$0.62 |
$2,735,930 |
I/I |
4,398,602 |
6,451,056 |
1.5 |
% |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2020-09-18 |
4 |
B |
$13.00 |
$9,999,990 |
I/I |
769,230 |
3,060,527 |
1.5 |
- |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2020-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,291,297 |
2,291,297 |
0 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2020-07-24 |
4 |
B |
$2.25 |
$7,090,335 |
I/I |
3,151,260 |
10,376,936 |
1.5 |
- |
|
| AKUS |
Akouos, Inc. |
10% Owner |
– – • |
2020-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
3,705,972 |
3,705,972 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
